Just another down ramper. At this stage why woukd we worry about competitor when really there is no a2 formula to sell. The chinese infant formula is worth 17bil and will increase to 30bil by 2018. How many companies similar to a2m and bal can enter the market and all will do well. Both a2m and bal if lucky, fy16 will do 800mil revenue. If half go to china thats only 400mil. Remember chinese are very selective of what they use. Bkl shares has been smashed the last few days because of their generic infant formula (just released) which offer no points of difference.
A2M $3 Party, page-28
-
- There are more pages in this discussion • 2,228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.48 |
Change
-0.110(1.67%) |
Mkt cap ! $4.684B | |||
| Open | High | Low | Value | Volume |
| $6.59 | $6.64 | $6.41 | $25.96M | 4.015M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103592 | $6.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.48 | 48180 | 4 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |